Lucid Diagnostics Inc. income statement

In fiscal 2025, Lucid Diagnostics Inc. reported revenue of $4.7m, up 8.3% on the year before, operating income of −$49.6m (a -1054.8% margin) and net income of −$58.0m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Lucid Diagnostics Inc.: income statement, annual
Fiscal year	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	1	0	2	4	5	5
Cost of revenue	1	100	—	7	7	—
Gross profit	1	0	—	−3	−2	—
Research and development	9	11	7	6	6	5
Selling, general and administrative	0	—	—	—	—	—
Selling and marketing	—	16	16	16	18	20
General and administrative	—	24	19	20	24	23
Operating income	−27	−56	−48	−46	−50	−51
Interest expense	1	0	0	0	0	0
Income before tax	−28	−56	−53	−46	−58	−52
Income tax	—	—	—	0	0	—
Net income	−28	−56	−53	−46	−58	−52
Diluted EPS	−$0.38	−$0.78	−$0.63	−$0.53	—	−$0.37
Diluted shares (average)	74m	72m	84m	101m	102m	141m
EBITDA	−27	−54	−46	−45	−49	−50

US$ millions unless shown otherwise. Fiscal quarters.

Lucid Diagnostics Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	1	1	1	1	1	2	1	1
Cost of revenue	—	—	2	2	—	—	2	1
Gross profit	—	—	−1	−0	—	—	−0	0
Research and development	2	1	1	1	1	2	1	1
Selling and marketing	4	4	4	4	4	5	5	6
General and administrative	5	6	6	6	6	6	5	6
Operating income	−12	−12	−12	−11	−12	−14	−12	−13
Interest expense	0	0	0	0	0	0	0	0
Income before tax	−12	−12	−27	−4	−10	−16	−14	−12
Income tax	—	—	0	0	—	—	0	0
Net income	−12	−12	−27	−4	−10	−16	−14	−12
Diluted EPS	−$0.25	−$0.18	−$0.52	−$0.08	−$0.10	—	—	—
EBITDA	−11	−12	−12	−11	−12	−14	−12	−13

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: LUCD vs NRXS BIAF vs LUCD LUCD vs MCTA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Lucid Diagnostics Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Lucid Diagnostics Inc.